Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia – The SALSA Randomized Clinical Trial

RCT (n=178, S Korea) reports no difference in overcorrection risk between rapid intermittent bolus and slow continuous infusion therapies; with overcorrection occurring in 17.2% vs. 24.2% of patients, respectively (absolute risk difference, −6.9% [95% CI, −18.8% to 4.9%]; p=0.26)

Source:

JAMA Internal Medicine